Literature DB >> 2499932

Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels.

C A Brown1, J V Hennessey.   

Abstract

The meaning of minor elevations in the thyrotropin level (less than 10 mIU/ml) in association with a normal thyroxine level has been questioned. Although such findings are presumed to be indicative of subclinical hypothyroidism, consideration of other causes can pose problems with diagnosis. We investigated the clinical significance of equivocal elevation of thyrotropin values with a normal thyroxine level and free thyroxine index in 31 patients evaluated with a thyrotropin releasing hormone (TRH) stimulation test and antithyroid antibody determinations. Patients were categorized as euthyroid or hypothyroid on the basis of TRH responsiveness. Of the 31 patients, 23 (74%) were hypothyroid, resulting in a positive predictive value as high as 81%. Eight of 21 hypothyroid patients (38%) had antimicrosomal antibodies, and only one euthyroid patient had antimicrosomal antibodies. We find that equivocally elevated thyrotropin values indicate primary hypothyroidism about 80% of the time. The combination of a mildly elevated thyrotropin level and antimicrosomal antibodies is seen almost exclusively in patients with thyroid failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499932     DOI: 10.1097/00007611-198906000-00003

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area.

Authors:  G Rivolta; R Cerutti; R Colombo; G Miano; P Dionisio; E Grossi
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Thyroid function in elderly people. Thyrotrophin releasing hormone test is useful.

Authors:  J Bolo-Deoku; O A Mojiminiyi; A H Wilcox; J L Barron
Journal:  BMJ       Date:  1993-09-18

3.  Thyroid antoantibodies and the response to thyrotropin releasing hormone in patients with subclinical hypothyroidism.

Authors:  O A Mojiminiyi; V Rege; J Bolodeoku; A H Wilcox; J L Barron
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.